Neovasc  logo
Neovasc NVCN

Annual report 2021
added 12-23-2023

report update icon

Neovasc Net Income 2011-2026 | NVCN

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Neovasc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-24.9 M -28.7 M -35.1 M -108 M -22.9 M -86.5 M -26.7 M -16.4 M -6.34 M -353 K -3.78 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-353 K -108 M -32.7 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer Net Income Price % 24h Market Cap Country
Alphatec Holdings Alphatec Holdings
ATEC
-143 M $ 11.75 -3.29 % $ 1.76 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
-10.3 M - 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
-18.6 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-59.7 M - - $ 3.31 B usaUSA
Delcath Systems Delcath Systems
DCTH
2.7 M $ 8.98 -1.32 % $ 322 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
53.4 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
-81.7 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-1.94 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
-12.3 M - -5.86 % $ 30.6 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
-23.5 M - -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
12.4 M $ 18.41 0.38 % $ 121 M usaUSA
Conformis Conformis
CFMS
-50.5 M - - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
-36.9 M - 0.15 % $ 844 M usaUSA
Inogen Inogen
INGN
-22.7 M $ 6.32 -2.02 % $ 168 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-39.8 M - - $ 475 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-9.57 M $ 1.35 - $ 21.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
22.5 M $ 100.97 1.78 % $ 1.28 B usaUSA
Avinger Avinger
AVGR
-18.3 M - -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
-16.7 M - -4.14 % $ 702 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
-242 M $ 62.4 -1.33 % $ 3.4 B britainBritain
LENSAR LENSAR
LNSR
-31.4 M $ 5.56 -8.4 % $ 64 M usaUSA
AxoGen AxoGen
AXGN
-15.7 M $ 32.61 2.71 % $ 1.5 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
47.1 M $ 36.56 -0.19 % $ 1.13 B usaUSA
Medtronic PLC Medtronic PLC
MDT
4.66 B $ 86.58 -0.68 % $ 111 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-14.5 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.14 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-10.9 M - 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
-3.7 M - - $ 1.08 M usaUSA
Electromed Electromed
ELMD
7.54 M $ 24.7 0.86 % $ 209 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
-17.4 M - - $ 462 M usaUSA
InspireMD InspireMD
NSPR
-48.8 M $ 1.79 3.47 % $ 115 M israelIsrael
Orthofix Medical Orthofix Medical
OFIX
-92.2 M $ 11.72 -1.26 % $ 464 M curacaoCuracao
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
-72.3 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-20.7 M $ 0.7 3.3 % $ 38.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
-13.4 M $ 2.16 -6.09 % $ 3.37 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
-30.7 M $ 5.15 -4.63 % $ 180 M canadaCanada
BIOLASE BIOLASE
BIOL
-20.6 M - -13.19 % $ 166 K usaUSA
Penumbra Penumbra
PEN
178 M $ 334.17 -0.41 % $ 13 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
-70.8 M $ 11.48 10.7 % $ 1.55 B usaUSA
Myomo Myomo
MYO
-15.6 M $ 0.7 -1.83 % $ 29.3 M usaUSA
Insulet Corporation Insulet Corporation
PODD
247 M $ 225.5 -0.7 % $ 15.9 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
-53.5 M $ 2.4 -1.64 % $ 141 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
-20.6 M - - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-19 M $ 3.91 4.83 % $ 146 M franceFrance
Quanterix Corporation Quanterix Corporation
QTRX
-107 M $ 3.82 -3.05 % $ 163 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
-39.6 M $ 15.91 -3.4 % $ 373 M usaUSA
Outset Medical Outset Medical
OM
-81.7 M $ 3.53 -2.35 % $ 53.7 K usaUSA